Share Price and Basic Stock Data
Last Updated: April 4, 2025, 10:56 am
PEG Ratio | 0.00 |
---|
Competitors of Spandana Sphoorty Financial Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
MKVentures Capital Ltd | 550 Cr. | 1,431 | 2,800/1,212 | 26.7 | 267 | 0.07 % | 20.6 % | 33.6 % | 10.0 |
Modern Shares & Stockbrokers Ltd | 14.6 Cr. | 49.8 | 69.4/36.0 | 41.7 | 43.9 | 0.00 % | 4.33 % | 3.24 % | 10.0 |
Monarch Networth Capital Ltd | 2,577 Cr. | 328 | 501/226 | 16.6 | 93.0 | 0.15 % | 51.8 % | 43.4 % | 10.0 |
Monotype India Ltd | 52.0 Cr. | 0.74 | 2.42/0.63 | 6.51 | 0.13 | 0.00 % | 438 % | % | 1.00 |
Multipurpose Trading & Agencies Ltd | 4.85 Cr. | 9.79 | 13.3/7.93 | 25.5 | 10.2 | 0.00 % | 4.44 % | 3.91 % | 10.0 |
Industry Average | 6,715.03 Cr | 1,388.24 | 84.40 | 5,208.09 | 0.37% | 18.65% | 17.36% | 7.36 |
Quarterly Result
Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 328 | 263 | 232 | 281 | 340 | 475 | 487 | 584 | 591 | 637 | 663 | 640 | 512 |
Interest | 132 | 102 | 92 | 88 | 118 | 146 | 195 | 223 | 241 | 239 | 246 | 245 | 213 |
Expenses | 144 | 148 | 451 | 127 | 141 | 202 | 155 | 231 | 217 | 261 | 370 | 682 | 837 |
Financing Profit | 52 | 13 | -311 | 66 | 81 | 127 | 137 | 131 | 133 | 138 | 47 | -287 | -538 |
Financing Margin % | 16% | 5% | -134% | 24% | 24% | 27% | 28% | 22% | 23% | 22% | 7% | -45% | -105% |
Other Income | 3 | 12 | 8 | 12 | 15 | 30 | 15 | 30 | 30 | 32 | 26 | 19 | 16 |
Depreciation | 2 | 3 | 2 | 2 | 3 | 4 | 3 | 5 | 6 | 7 | 4 | 5 | 5 |
Profit before tax | 53 | 23 | -305 | 76 | 94 | 153 | 149 | 156 | 158 | 164 | 69 | -272 | -526 |
Tax % | 24% | 19% | -27% | 35% | 26% | 24% | 25% | 25% | 25% | 25% | 26% | -25% | -25% |
Net Profit | 40 | 18 | -223 | 50 | 69 | 116 | 111 | 116 | 118 | 122 | 51 | -204 | -394 |
EPS in Rs | 6.17 | 2.64 | -31.39 | 6.98 | 9.76 | 16.37 | 15.65 | 16.36 | 16.62 | 17.14 | 7.19 | -28.60 | -55.24 |
Gross NPA % | 17.70% | 1.95% | 1.49% | 1.27% | 1.50% | 1.43% | 2.60% | 4.88% | 4.85% | ||||
Net NPA % | 0.64% | 0.45% | 0.38% | 0.45% | 0.29% | 0.52% | 0.97% | 0.96% |
Last Updated: February 28, 2025, 5:00 pm
Below is a detailed analysis of the quarterly data for Spandana Sphoorty Financial Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Interest, as of Dec 2024, the value is ₹213.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 245.00 Cr. (Sep 2024) to ₹213.00 Cr., marking a decrease of 32.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹837.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 682.00 Cr. (Sep 2024) to ₹837.00 Cr., marking an increase of 155.00 Cr..
- For Other Income, as of Dec 2024, the value is ₹16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Sep 2024) to ₹16.00 Cr., marking a decrease of 3.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹5.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 5.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹-526.00 Cr.. The value appears to be declining and may need further review. It has decreased from -272.00 Cr. (Sep 2024) to ₹-526.00 Cr., marking a decrease of 254.00 Cr..
- For Tax %, as of Dec 2024, the value is -25.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded -25.00%.
- For Net Profit, as of Dec 2024, the value is ₹-394.00 Cr.. The value appears to be declining and may need further review. It has decreased from -204.00 Cr. (Sep 2024) to ₹-394.00 Cr., marking a decrease of 190.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is -55.24. The value appears to be declining and may need further review. It has decreased from -28.60 (Sep 2024) to -55.24, marking a decrease of 26.64.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 2:47 pm
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 258 | 280 | 303 | 345 | 378 | 587 | 1,036 | 1,409 | 1,444 | 1,376 | 1,329 | 2,300 | 2,453 |
Interest | 6 | 100 | 112 | 129 | 150 | 232 | 358 | 357 | 419 | 515 | 447 | 900 | 943 |
Expenses | 1,427 | 113 | 104 | 219 | 196 | 67 | 207 | 477 | 860 | 803 | 919 | 861 | 2,150 |
Financing Profit | -1,174 | 67 | 87 | -4 | 32 | 288 | 471 | 575 | 164 | 58 | -37 | 539 | -640 |
Financing Margin % | -455% | 24% | 29% | -1% | 9% | 49% | 45% | 41% | 11% | 4% | -3% | 23% | -26% |
Other Income | 14 | 1 | 22 | 251 | 22 | 0 | 5 | 32 | 21 | 15 | 66 | 107 | 94 |
Depreciation | 3 | 3 | 3 | 4 | 8 | 6 | 7 | 9 | 7 | 9 | 11 | 20 | 20 |
Profit before tax | -1,163 | 64 | 106 | 243 | 46 | 283 | 469 | 598 | 178 | 65 | 18 | 626 | -565 |
Tax % | 0% | 0% | 1% | 0% | -873% | 34% | 34% | 44% | 27% | 28% | 32% | 25% | |
Net Profit | -1,163 | 64 | 105 | 243 | 443 | 188 | 309 | 337 | 129 | 47 | 12 | 468 | -424 |
EPS in Rs | -599.88 | 33.18 | 51.57 | 119.35 | 155.86 | 63.17 | 51.77 | 52.35 | 20.05 | 6.75 | 1.74 | 65.62 | -59.51 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 105.50% | 64.06% | 131.43% | 82.30% | -57.56% | 64.36% | 9.06% | -61.72% | -63.57% | -74.47% | 3800.00% |
Change in YoY Net Profit Growth (%) | 0.00% | -41.44% | 67.37% | -49.12% | -139.87% | 121.92% | -55.30% | -70.78% | -1.84% | -10.90% | 3874.47% |
Spandana Sphoorty Financial Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 23% |
5 Years: | 17% |
3 Years: | 17% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | 22% |
5 Years: | 9% |
3 Years: | 54% |
TTM: | -192% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -17% |
3 Years: | -19% |
1 Year: | -73% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 7% |
3 Years: | 6% |
Last Year: | 14% |
Last Updated: Unknown
Balance Sheet
Last Updated: March 14, 2025, 2:48 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 19 | 19 | 20 | 20 | 28 | 30 | 60 | 64 | 64 | 69 | 71 | 71 | 71 |
Reserves | -970 | -924 | -864 | -627 | -2 | 216 | 1,827 | 2,544 | 2,652 | 2,962 | 2,972 | 3,485 | 3,355 |
Deposits | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 1,983 | 1,596 | 1,831 | 1,710 | 1,834 | 3,477 | 2,945 | 3,016 | 5,197 | 3,631 | 5,934 | 9,012 | 7,331 |
Other Liabilities | 1,545 | 1,482 | 1,365 | 997 | 68 | 42 | 67 | 317 | 433 | 201 | 208 | 301 | 176 |
Total Liabilities | 2,577 | 2,173 | 2,352 | 2,100 | 1,929 | 3,764 | 4,898 | 5,942 | 8,346 | 6,864 | 9,186 | 12,870 | 10,932 |
Fixed Assets | 7 | 4 | 6 | 14 | 9 | 8 | 9 | 16 | 20 | 14 | 29 | 32 | 30 |
CWIP | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 2 | 65 | 550 | 115 | 115 | 306 | 329 | 327 |
Other Assets | 2,571 | 2,169 | 2,341 | 2,085 | 1,920 | 3,754 | 4,824 | 5,375 | 8,211 | 6,736 | 8,850 | 12,509 | 10,575 |
Total Assets | 2,577 | 2,173 | 2,352 | 2,100 | 1,929 | 3,764 | 4,898 | 5,942 | 8,346 | 6,864 | 9,186 | 12,870 | 10,932 |
Below is a detailed analysis of the balance sheet data for Spandana Sphoorty Financial Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹71.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 71.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹3,355.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,485.00 Cr. (Mar 2024) to ₹3,355.00 Cr., marking a decrease of 130.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹7,331.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 9,012.00 Cr. (Mar 2024) to ₹7,331.00 Cr., marking a decrease of 1,681.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹176.00 Cr.. The value appears to be improving (decreasing). It has decreased from 301.00 Cr. (Mar 2024) to ₹176.00 Cr., marking a decrease of 125.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹10,932.00 Cr.. The value appears to be improving (decreasing). It has decreased from 12,870.00 Cr. (Mar 2024) to ₹10,932.00 Cr., marking a decrease of 1,938.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹30.00 Cr.. The value appears to be declining and may need further review. It has decreased from 32.00 Cr. (Mar 2024) to ₹30.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Sep 2024, the value is ₹327.00 Cr.. The value appears to be declining and may need further review. It has decreased from 329.00 Cr. (Mar 2024) to ₹327.00 Cr., marking a decrease of 2.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹10,575.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12,509.00 Cr. (Mar 2024) to ₹10,575.00 Cr., marking a decrease of 1,934.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹10,932.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12,870.00 Cr. (Mar 2024) to ₹10,932.00 Cr., marking a decrease of 1,938.00 Cr..
However, the Borrowings (7,331.00 Cr.) are higher than the Reserves (₹3,355.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 1.00 | 113.00 | 104.00 | 219.00 | 196.00 | 67.00 | 207.00 | 477.00 | 860.00 | 803.00 | 919.00 | 861.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROE % | 138% | 29% | 15% | 5% | 2% | 0% | 14% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
Edelweiss Small Cap Fund | 415,729 | 1.56 | 46.92 | 334,527 | 2025-04-03 | 24.27% |
Edelweiss Mid Cap Fund | 334,527 | 0.82 | 37.76 | 334,527 | 2025-04-03 | 0% |
Tata Banking and Financial Services Fund | 300,000 | 1.75 | 33.86 | 334,527 | 2025-04-03 | -10.32% |
Union Flexi Cap Fund | 265,000 | 1.6 | 29.91 | 334,527 | 2025-04-03 | -20.78% |
Union Small Cap Fund | 244,751 | 2.15 | 27.63 | 334,527 | 2025-04-03 | -26.84% |
JM Flexicap Fund | 125,000 | 1.14 | 14.11 | 334,527 | 2025-04-03 | -62.63% |
Union Multicap Fund | 117,800 | 1.77 | 13.3 | 334,527 | 2025-04-03 | -64.79% |
Union Innovation & Opportunities Fund | 105,233 | 2.09 | 11.88 | 334,527 | 2025-04-03 | -68.54% |
Union Midcap Fund | 102,958 | 1.19 | 11.62 | 334,527 | 2025-04-03 | -69.22% |
JM Value Fund | 97,500 | 2.71 | 11 | 334,527 | 2025-04-03 | -70.85% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 70.42 | 1.74 | 10.75 | 22.55 | 56.21 |
Diluted EPS (Rs.) | 69.38 | 1.74 | 10.72 | 22.47 | 55.74 |
Cash EPS (Rs.) | 73.09 | 3.28 | 11.43 | 23.80 | 56.08 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 511.20 | 436.62 | 447.20 | 427.75 | 408.50 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 511.20 | 436.62 | 447.20 | 427.75 | 408.50 |
Revenue From Operations / Share (Rs.) | 339.93 | 197.34 | 211.71 | 230.53 | 223.17 |
PBDIT / Share (Rs.) | 226.89 | 68.55 | 93.52 | 98.15 | 152.94 |
PBIT / Share (Rs.) | 224.03 | 67.02 | 92.19 | 96.96 | 151.56 |
PBT / Share (Rs.) | 94.05 | 2.51 | 14.02 | 31.17 | 96.16 |
Net Profit / Share (Rs.) | 70.23 | 1.75 | 10.11 | 22.62 | 54.70 |
NP After MI And SOA / Share (Rs.) | 70.22 | 1.73 | 10.05 | 22.55 | 54.65 |
PBDIT Margin (%) | 66.74 | 34.73 | 44.17 | 42.57 | 68.53 |
PBIT Margin (%) | 65.90 | 33.96 | 43.54 | 42.06 | 67.91 |
PBT Margin (%) | 27.66 | 1.27 | 6.62 | 13.51 | 43.08 |
Net Profit Margin (%) | 20.65 | 0.88 | 4.77 | 9.81 | 24.51 |
NP After MI And SOA Margin (%) | 20.65 | 0.87 | 4.74 | 9.78 | 24.48 |
Return on Networth / Equity (%) | 13.73 | 0.39 | 2.24 | 5.27 | 13.38 |
Return on Capital Employeed (%) | 20.50 | 7.27 | 12.81 | 12.50 | 27.67 |
Return On Assets (%) | 3.74 | 0.13 | 0.98 | 1.69 | 5.87 |
Long Term Debt / Equity (X) | 1.12 | 1.09 | 0.58 | 0.74 | 0.30 |
Total Debt / Equity (X) | 2.59 | 1.96 | 1.22 | 1.95 | 1.15 |
Asset Turnover Ratio (%) | 0.21 | 0.16 | 0.17 | 0.20 | 0.25 |
Current Ratio (X) | 2.34 | 3.20 | 3.24 | 2.34 | 2.41 |
Quick Ratio (X) | 2.34 | 3.19 | 3.24 | 2.34 | 2.41 |
Interest Coverage Ratio (X) | 1.75 | 1.06 | 1.20 | 1.49 | 2.76 |
Interest Coverage Ratio (Post Tax) (X) | 1.54 | 1.03 | 1.13 | 1.34 | 1.99 |
Enterprise Value (Cr.) | 13537.08 | 8850.52 | 4868.61 | 7881.14 | 6545.70 |
EV / Net Operating Revenue (X) | 5.59 | 6.32 | 3.33 | 5.32 | 4.56 |
EV / EBITDA (X) | 8.37 | 18.19 | 7.53 | 12.49 | 6.65 |
MarketCap / Net Operating Revenue (X) | 2.48 | 2.70 | 1.57 | 2.62 | 2.63 |
Price / BV (X) | 1.65 | 1.22 | 0.74 | 1.41 | 1.44 |
Price / Net Operating Revenue (X) | 2.48 | 2.70 | 1.57 | 2.62 | 2.63 |
EarningsYield | 0.08 | 0.00 | 0.03 | 0.03 | 0.09 |
After reviewing the key financial ratios for Spandana Sphoorty Financial Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 70.42. This value is within the healthy range. It has increased from 1.74 (Mar 23) to 70.42, marking an increase of 68.68.
- For Diluted EPS (Rs.), as of Mar 24, the value is 69.38. This value is within the healthy range. It has increased from 1.74 (Mar 23) to 69.38, marking an increase of 67.64.
- For Cash EPS (Rs.), as of Mar 24, the value is 73.09. This value is within the healthy range. It has increased from 3.28 (Mar 23) to 73.09, marking an increase of 69.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 511.20. It has increased from 436.62 (Mar 23) to 511.20, marking an increase of 74.58.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 511.20. It has increased from 436.62 (Mar 23) to 511.20, marking an increase of 74.58.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 339.93. It has increased from 197.34 (Mar 23) to 339.93, marking an increase of 142.59.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 226.89. This value is within the healthy range. It has increased from 68.55 (Mar 23) to 226.89, marking an increase of 158.34.
- For PBIT / Share (Rs.), as of Mar 24, the value is 224.03. This value is within the healthy range. It has increased from 67.02 (Mar 23) to 224.03, marking an increase of 157.01.
- For PBT / Share (Rs.), as of Mar 24, the value is 94.05. This value is within the healthy range. It has increased from 2.51 (Mar 23) to 94.05, marking an increase of 91.54.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 70.23. This value is within the healthy range. It has increased from 1.75 (Mar 23) to 70.23, marking an increase of 68.48.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 70.22. This value is within the healthy range. It has increased from 1.73 (Mar 23) to 70.22, marking an increase of 68.49.
- For PBDIT Margin (%), as of Mar 24, the value is 66.74. This value is within the healthy range. It has increased from 34.73 (Mar 23) to 66.74, marking an increase of 32.01.
- For PBIT Margin (%), as of Mar 24, the value is 65.90. This value exceeds the healthy maximum of 20. It has increased from 33.96 (Mar 23) to 65.90, marking an increase of 31.94.
- For PBT Margin (%), as of Mar 24, the value is 27.66. This value is within the healthy range. It has increased from 1.27 (Mar 23) to 27.66, marking an increase of 26.39.
- For Net Profit Margin (%), as of Mar 24, the value is 20.65. This value exceeds the healthy maximum of 10. It has increased from 0.88 (Mar 23) to 20.65, marking an increase of 19.77.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 20.65. This value exceeds the healthy maximum of 20. It has increased from 0.87 (Mar 23) to 20.65, marking an increase of 19.78.
- For Return on Networth / Equity (%), as of Mar 24, the value is 13.73. This value is below the healthy minimum of 15. It has increased from 0.39 (Mar 23) to 13.73, marking an increase of 13.34.
- For Return on Capital Employeed (%), as of Mar 24, the value is 20.50. This value is within the healthy range. It has increased from 7.27 (Mar 23) to 20.50, marking an increase of 13.23.
- For Return On Assets (%), as of Mar 24, the value is 3.74. This value is below the healthy minimum of 5. It has increased from 0.13 (Mar 23) to 3.74, marking an increase of 3.61.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 1.12. This value exceeds the healthy maximum of 1. It has increased from 1.09 (Mar 23) to 1.12, marking an increase of 0.03.
- For Total Debt / Equity (X), as of Mar 24, the value is 2.59. This value exceeds the healthy maximum of 1. It has increased from 1.96 (Mar 23) to 2.59, marking an increase of 0.63.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.21. It has increased from 0.16 (Mar 23) to 0.21, marking an increase of 0.05.
- For Current Ratio (X), as of Mar 24, the value is 2.34. This value is within the healthy range. It has decreased from 3.20 (Mar 23) to 2.34, marking a decrease of 0.86.
- For Quick Ratio (X), as of Mar 24, the value is 2.34. This value exceeds the healthy maximum of 2. It has decreased from 3.19 (Mar 23) to 2.34, marking a decrease of 0.85.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 1.75. This value is below the healthy minimum of 3. It has increased from 1.06 (Mar 23) to 1.75, marking an increase of 0.69.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.54. This value is below the healthy minimum of 3. It has increased from 1.03 (Mar 23) to 1.54, marking an increase of 0.51.
- For Enterprise Value (Cr.), as of Mar 24, the value is 13,537.08. It has increased from 8,850.52 (Mar 23) to 13,537.08, marking an increase of 4,686.56.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.59. This value exceeds the healthy maximum of 3. It has decreased from 6.32 (Mar 23) to 5.59, marking a decrease of 0.73.
- For EV / EBITDA (X), as of Mar 24, the value is 8.37. This value is within the healthy range. It has decreased from 18.19 (Mar 23) to 8.37, marking a decrease of 9.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.48. This value is within the healthy range. It has decreased from 2.70 (Mar 23) to 2.48, marking a decrease of 0.22.
- For Price / BV (X), as of Mar 24, the value is 1.65. This value is within the healthy range. It has increased from 1.22 (Mar 23) to 1.65, marking an increase of 0.43.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.48. This value is within the healthy range. It has decreased from 2.70 (Mar 23) to 2.48, marking a decrease of 0.22.
- For EarningsYield, as of Mar 24, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 23) to 0.08, marking an increase of 0.08.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Spandana Sphoorty Financial Ltd:
- Net Profit Margin: 20.65%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.5% (Industry Average ROCE: 18.65%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.73% (Industry Average ROE: 17.36%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.54
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.34
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 84.4)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.59
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 20.65%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Microfinance Institutions | Galaxy, Wing B, 16th Floor, Plot No.1, Sy No 83/1, Hyderabad Knowledge City, Hyderabad Telangana 500081 | secretarial@spandanasphoorty.com http://www.spandanasphoorty.com |
Management | |
---|---|
Name | Position Held |
Ms. Abanti Mitra | Chairman & Ind.Director |
Mr. Shalabh Saxena | Managing Director & CEO |
Mr. Animesh Chauhan | Independent Director |
Mr. Deepak Calian Vaidya | Independent Director |
Mr. Vinayak Prasad | Independent Director |
Mrs. Dipali Hemant Sheth | Independent Director |
Ms. Saakshi Gera | Non Exe. & Nominee Director |
Mr. Neeraj Swaroop | Non Exe. & Nominee Director |
Mr. Sunish Sharma | Non Exe. & Nominee Director |
Mr. Ramachandra K Kamath | Non Exe. & Nominee Director |
FAQ
What is the intrinsic value of Spandana Sphoorty Financial Ltd?
Spandana Sphoorty Financial Ltd's intrinsic value (as of 04 April 2025) is ₹834.28 — 244.74% higher the current market price of ₹242.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 1,723 Cr. market cap, FY2025-2026 high/low of ₹936/230, reserves of 3,355 Cr, and liabilities of 10,932 Cr.
What is the Market Cap of Spandana Sphoorty Financial Ltd?
The Market Cap of Spandana Sphoorty Financial Ltd is 1,723 Cr..
What is the current Stock Price of Spandana Sphoorty Financial Ltd as on 04 April 2025?
The current stock price of Spandana Sphoorty Financial Ltd as on 04 April 2025 is 242.
What is the High / Low of Spandana Sphoorty Financial Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Spandana Sphoorty Financial Ltd stocks is ₹936/230.
What is the Stock P/E of Spandana Sphoorty Financial Ltd?
The Stock P/E of Spandana Sphoorty Financial Ltd is .
What is the Book Value of Spandana Sphoorty Financial Ltd?
The Book Value of Spandana Sphoorty Financial Ltd is 480.
What is the Dividend Yield of Spandana Sphoorty Financial Ltd?
The Dividend Yield of Spandana Sphoorty Financial Ltd is 0.00 %.
What is the ROCE of Spandana Sphoorty Financial Ltd?
The ROCE of Spandana Sphoorty Financial Ltd is 14.2 %.
What is the ROE of Spandana Sphoorty Financial Ltd?
The ROE of Spandana Sphoorty Financial Ltd is 14.2 %.
What is the Face Value of Spandana Sphoorty Financial Ltd?
The Face Value of Spandana Sphoorty Financial Ltd is 10.0.